Clinical Trial Update: A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients. [Phase 2]

View source ↗

Summary

A Phase 2, one-arm exploratory trial evaluating apatinib in patients with advanced/metastatic renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN